Robert Pickett Dickson, MD
Galen B Toews M.D. Legacy Professor of Pulmonary and Critical Care Medicine
Associate Professor of Internal Medicine
Associate Professor of Microbiology and Immunology
Associate Fellowship Director, Pulmonary and Critical Care Medicine
[email protected]

Available to mentor

Robert Pickett Dickson, MD
Associate Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • About

    Robert Dickson is the Galen B. Toews Legacy Professor of Pulmonary and Critical Care Medicine at the University of Medicine, and an Associate Professor in the Division of Pulmonary and Critical Care Medicine and the Department of Microbiology and Immunology at the University of Michigan. Clinically, he cares for patient in the Critical Care Medicine Unit and serves as the program physician for the Washtenaw County Tuberculosis Clinic.

    Dr. Dickson serves as Associate Chief (Research) for the Division of Pulmonary & Critical Care Medicine and as Deputy Director of the Weil Institute for Critical Care Research & Innovation. He is the Program Director of the University of Michigan’s Multidisciplinary Training Program in Lung Disease (T32HL007749), and Associate Program Director (Research) for the Pulmonary and Critical Care Medicine Fellowship Program.

    Qualifications
    • MD
      Duke University, Durham, 2007
    • BA
      St. John's College, Annapolis, 2000
    Center Memberships
    • Center Member
      Center for Integrative Research in Critical Care
    • Center Member
      MM-PKUHSC Joint Institute
    • Center Member
      Global REACH
    Research Overview

    In the lab, Dr. Dickson complements his clinical and research background in the pathophysiology of lung disease and critical illness with the culture-independent techniques of microbial ecology. Diseases of interest include the acute respiratory distress syndrome (ARDS), sepsis, pneumonia, pulmonary fibrosis, and lung transplant rejection. His laboratory specializes in integrative translational research, spanning from molecular characterization of respiratory microbiota to animal modeling of sepsis and lung injury to prospective trials of human subjects.

    Dr. Dickson's expertise in the study of the microbiome's role in critical illness and lung disease is reflected by first- and senior-author publications in Science Translational Medicine, Nature Microbiology, The Lancet, the American Journal of Respiratory and Critical Care Medicine and Lancet Respiratory Medicine. He has authored more than 125 publications which have been cited more than 12,000 times. His research is supported by the National Institutes for Health, the European Commission, and institutional support.

    He is a Specialist Editor of the European Respiratory Journal, and a member of the Editorial Boards of the American Journal of Respiratory and Critical Care Medicine and Lancet Respiratory Medicine. He is an elected member of the American Society for Clinical Investigation, and a Fellow of the European Respiratory Society.

    Recent Publications See All Publications
    • Journal Article
      Estimating the Population-Level Impact of Empiric Anti-Anaerobic Antibiotics among US Adults Hospitalized with Sepsis.
      Admon AJ, Sjoding MW, Prescott HC, Chanderraj R, Dickson RP. Am J Respir Crit Care Med, 2024 Nov 12; DOI:10.1164/rccm.202405-0955RL
      PMID: 39531631
    • Journal Article
      Development of a rapid, culture-free, universal microbial identification system using internal transcribed spacer targeting primers.
      Asthana V, Nieves EM, Bugga P, Smith C, Dunn T, Narayanasamy S, Dickson RP, VanEpps JS. J Infect Dis, 2024 Nov 6; DOI:10.1093/infdis/jiae545
      PMID: 39503259
    • Preprint
      High-throughput, Multiplexed Assay Platform for Integrated Analysis of Sepsis
      Min J, Lim Y, Tokmedash MA, Allen M, Gruich C, Choi JH, Kim C, Goldsmith B, Dickson R, Bong KW. 2024 Oct 24; Springer Science and Business Media LLC, DOI:10.21203/rs.3.rs-5256006/v1
    • Journal Article
      Empirical antibiotic therapy for sepsis: save the anaerobic microbiota.
      Kullberg RFJ, Haak BW, Chanderraj R, Prescott HC, Dickson RP, Wiersinga WJ. Lancet Respir Med, 2024 Oct 11; DOI:10.1016/S2213-2600(24)00257-1
      PMID: 39401510
    • Preprint
      GenomicGapID: Leveraging Spatial Distribution of Conserved Genomic Sites for Broad-Spectrum Microbial Identification
      Asthana V, Bugga P, Smith CE, Wellman C, Dwight Z, Ranjan P, Nieves EM, Dickson R, VanEpps S. 2024 bioRxiv, DOI:10.1101/2024.10.07.617038
    • Journal Article
      Reevaluating Piperacillin-Tazobactam Mortality-Reply.
      Chanderraj R, Dickson RP, Sjoding MW. JAMA Intern Med, 2024 Oct 1; 184 (10): 1269 DOI:10.1001/jamainternmed.2024.4120
      PMID: 39186296
    • Preprint
      A rapid, inexpensive, culture-free, universal bacterial identification system using internal transcribed spacer targeting primers: a proof-of-principle study
      Asthana V, Nieves EM, Bugga P, Smith C, Dunn T, Narayanasamy S, Dickson R, VanEpps S. 2024 bioRxiv, DOI:10.1101/2024.09.15.613074
    • Preprint
      Respiratory virome convergence precedes Hospital-Acquired Pneumonia in critically ill patients
      Josset L, Anani H, Destras G, Bulteau S, Castain L, Semanas Q, Burfin G, Martin F, Poulain C, Dickson R, Bressollette-Bodin C, Roquilly A. 2024 Research Square, DOI:10.21203/rs.3.rs-4808570/v1
    Featured News & Stories Jennifer Baker Headshot
    Points of Blue
    Jennifer Baker, PhD Candidate: Running the PhD marathon
    Jennifer Baker is a PhD Candidate in the Microbiology & Immunology Program.